FDA NDC Directory · JSON-LD · Markdown

ARANESP

NDC 55513-021 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Generic namedarbepoetin alfa
Labeler / ManufacturerAmgen, Inc
Marketing categoryBiologic License Application · App BLA103951
Dosage form / routeINJECTION, SOLUTION · INTRAVENOUS SUBCUTANEOUS
Active ingredientsDARBEPOETIN ALFA (40 ug/.4mL)
Marketing started20060814
Package count1

External sources

Source: openFDA. Public-domain (CC0).